Page last updated: 2024-08-24

triazoles and osteoprotegerin

triazoles has been researched along with osteoprotegerin in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bajetta, E; Bombardieri, E; Del Vecchio, M; Ferrari, L; La Torre, I; Longarini, R; Martinetti, A; Paleari, D; Seregni, E; Toffolatti, L; Zilembo, N	1
Finkelstein, JS; Leder, BZ	1

Trials

1 trial(s) available for triazoles and osteoprotegerin

Article	Year
Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2005, Volume: 16, Issue:12 Topics: Aged; Anastrozole; Aromatase Inhibitors; Biomarkers; Bone and Bones; Bone Resorption; Estradiol; Glycoproteins; Humans; Hypogonadism; Male; Nitriles; Osteoprotegerin; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Testosterone; Triazoles	2005

Article

Year

Effect of aromatase inhibition on bone metabolism in elderly hypogonadal men.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 2005, Volume: 16, Issue:12

Topics: Aged; Anastrozole; Aromatase Inhibitors; Biomarkers; Bone and Bones; Bone Resorption; Estradiol; Glycoproteins; Humans; Hypogonadism; Male; Nitriles; Osteoprotegerin; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Testosterone; Triazoles

2005

Other Studies

1 other study(ies) available for triazoles and osteoprotegerin

Article	Year
Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole. Endocrine-related cancer, 2004, Volume: 11, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Female; Glycoproteins; Humans; Middle Aged; Nitriles; Osteopontin; Osteoprotegerin; Postmenopause; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Sialoglycoproteins; Survival Analysis; Triazoles	2004

Article

Year

Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole.

Endocrine-related cancer, 2004, Volume: 11, Issue:4

Topics: Adult; Aged; Aged, 80 and over; Anastrozole; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Bone Neoplasms; Breast Neoplasms; Female; Glycoproteins; Humans; Middle Aged; Nitriles; Osteopontin; Osteoprotegerin; Postmenopause; Receptors, Cytoplasmic and Nuclear; Receptors, Tumor Necrosis Factor; Sialoglycoproteins; Survival Analysis; Triazoles

2004